Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Baocuo Gong, Xuewen Wang, Wanting Guo, Hongyi Yang, Yanhong Shi, Yaying Chen, Simiao Gao, Jialin Chen, Lifang Liu, Linbin Lu & Xiong Chen. (2023) Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score. Journal of Hepatocellular Carcinoma 10, pages 1341-1351.
Read now
Read now
Nisha A. Lakhi & Gerald J. Mizejewski. (2017) Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility. Fetal and Pediatric Pathology 36:1, pages 49-61.
Read now
Read now
Gerald J Mizejewski. (2016) Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary. Journal of Hepatocellular Carcinoma 3, pages 37-40.
Read now
Read now
Fan Zhou, Zengyao Li, Zengtao Bao, Kang Feng, Ye Zhang & Tong Wang. (2015) Highly sensitive, label-free and real-time detection of alpha-fetoprotein using a silicon nanowire biosensor. Scandinavian Journal of Clinical and Laboratory Investigation 75:7, pages 578-584.
Read now
Read now
G. J. Mizejewski. (2015) The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets. Journal of Drug Targeting 23:6, pages 538-551.
Read now
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Read now
Angela D. Pardee & Lisa H. Butterfield. (2012) Immunotherapy of hepatocellular carcinoma. OncoImmunology 1:1, pages 48-55.
Read now
Read now
GJ Mizejewski, M Mirowski, P Garnuszek, M Maurin, BD Cohen, BJ Poiesz, GA Posypanova, VA Makarov, ES Severin & SE Severin. (2010) Targeted delivery of anti-cancer growth inhibitory peptides derived from human α-fetoprotein: review of an International Multi-Center Collaborative Study. Journal of Drug Targeting 18:8, pages 575-588.
Read now
Read now
Deepti Srinivas Wilkinson, Wen-Wei Tsai, Maria A. Schumacher & Michelle Craig Barton. (2008) Chromatin-Bound p53 Anchors Activated Smads and the mSin3A Corepressor To Confer Transforming Growth Factor β-Mediated Transcription Repression. Molecular and Cellular Biology 28:6, pages 1988-1998.
Read now
Read now
Articles from other publishers (77)
Patricia Griffin, Wendy A. Hill, Fabio Rossi, Rebecca Boohaker, Karr Stinson & Igor Sherman. (2023) High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model. Cancer Cell International 23:1.
Crossref
Crossref
Jiaoxia He, Zhongling Zheng, Tingting Liu, Yupei Ao, Yixuan Yang & Huaidong Hu. (2022) Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma. Scientific Reports 12:1.
Crossref
Crossref
Min Wang, Mingzhe Jiang, Xiaochen Liao, Xiao Wang, Wenjing Lai, Pengli Li, Jiajia Li, Chenglin Hong & Yu Qi. (2022)
Preparation of an electrochemical immunosensor based on a Cu/Cu
2
O-rGO@Au signal synergistic amplification strategy and efficient and sensitive detection of alpha-fetoprotein
. Analytical Methods 14:27, pages 2703-2713.
Crossref
Crossref
Xuyong Wei, Renyi Su, Mengfan Yang, Binhua Pan, Jun Lu, Hanchao Lin, Wenzhi Shu, Rui Wang & Xiao Xu. (2022) Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level. Translational Oncology 20, pages 101422.
Crossref
Crossref
Tomoaki Hishida, Mako Yamamoto, Yuriko Hishida-Nozaki, Changwei Shao, Ling Huang, Chao Wang, Kensaku Shojima, Yuan Xue, Yuqing Hang, Maxim Shokhirev, Sebastian Memczak, Sanjeeb Kumar Sahu, Fumiyuki Hatanaka, Ruben Rabadan Ros, Matthew B. Maxwell, Jasmine Chavez, Yanjiao Shao, Hsin-Kai Liao, Paloma Martinez-Redondo, Isabel Guillen-Guillen, Reyna Hernandez-Benitez, Concepcion Rodriguez Esteban, Jing Qu, Michael C. Holmes, Fei Yi, Raymond D. Hickey, Pedro Guillen Garcia, Estrella Nuñez Delicado, Antoni Castells, Josep M. Campistol, Yang Yu, Diana C. Hargreaves, Akihiro Asai, Pradeep Reddy, Guang-Hui Liu & Juan Carlos Izpisua Belmonte. (2022) In vivo partial cellular reprogramming enhances liver plasticity and regeneration. Cell Reports 39:4, pages 110730.
Crossref
Crossref
Ahmed A. Mohamed, Randa A. Zaghloul, Amr M. Abdelghany & Amal M. El Gayar. (2022) Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement. Journal of Biochemical and Molecular Toxicology 36:4.
Crossref
Crossref
Ying Lin, Xiaodan Zong, Mingkai Li, Sizhe Wan, Hongsheng Yu & Xiuqing Wei. (2022) Marked elevation of serum alpha-fetoprotein following Clonorchis sinensis infection: A rare case report. Liver Research 6:1, pages 45-49.
Crossref
Crossref
Dan-Ping Huang, Mian-Mian Liao, Jing-Jing Tong, Wei-Qu Yuan, De-Ti Peng, Jian-Ping Lai, Yi-Hao Zeng, Yi-Jun Qiu & Guang-Dong Tong. (2021) Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma. Aging 13:22, pages 24621-24639.
Crossref
Crossref
Vandana M. SagarKathyrn HerringStuart Curbishley, James Hodson, Peter Fletcher, Salil Karkhanis, Homoyon Mehrzad, Pankaj Punia, Tahir Shah, Shishir ShettyYuk Ting Ma. (2021) The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study. Oncotarget 12:24, pages 2338-2350.
Crossref
Crossref
Snehasis Bhakta & Prashant Mishra. (2021) Molecularly imprinted polymer-based sensors for cancer biomarker detection. Sensors and Actuators Reports 3, pages 100061.
Crossref
Crossref
Bo Lin, Xu Dong, Qiujiao Wang, Wei Li, Mingyue Zhu & Mengsen Li. (2021) AFP-Inhibiting Fragments for Drug Delivery: The Promise and Challenges of Targeting Therapeutics to Cancers. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Nurbubu Moldogazieva, Innokenty Mokhosoev, Sergey Zavadskiy & Alexander Terentiev. (2021) Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 9:2, pages 159.
Crossref
Crossref
O. K. Gulevskyy. (2021) URRENT CONCEPT OF THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF ALFA-FETOPROTEIN AND THE POSSIBILITIES OF ITS CLINICAL APPLICATION. Biotechnologia Acta 14:1, pages 25-37.
Crossref
Crossref
Hebatallah Adel Sedky, Soha Raouf Youssef, Doaa Ahmad Gamal, Heba Fawzy Houssein & Walaa Ali Elsalakawy. (2020) First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients. BLOOD RESEARCH 55:4, pages 253-261.
Crossref
Crossref
Tianke Chen, Xiaowei Dai, Juji Dai, Chaodong Ding, Zheng Zhang, Ziqi Lin, Jin Hu, Mei Lu, Zhanyu Wang, Yalei Qi, Li Zhang, Rulu Pan, Zhu Zhao, Liting Lu, Wanqin Liao & Xincheng Lu. (2020) AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death & Disease 11:10.
Crossref
Crossref
Zhenjuan Li, Haiping Gong, Qiuping Liu, Wanli Wu, Jianting Cheng, Yingyi Mei, Yaolong Chen, Hongjun Zheng, Xiaohong Yu, Shi Zhong & Yi Li. (2020)
Identification of an HLA‐A*24:02‐restricted
α
‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
. Immunology 159:4, pages 384-392.
Crossref
Crossref
Nurbubu T. Moldogazieva, Daria S. Ostroverkhova, Nikolai N. Kuzmich, Vladimir V. Kadochnikov, Alexander A. Terentiev & Yuri B. Porozov. (2020) Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis. International Journal of Molecular Sciences 21:3, pages 893.
Crossref
Crossref
Patric Teodorescu, Sergiu Pasca & Ciprian Tomuleasa. 2020. Pineal Region Lesions. Pineal Region Lesions
45
49
.
Robert Montal, Carmen Andreu-Oller, Laia Bassaganyas, Roger Esteban-Fabró, Sebastián Moran, Carla Montironi, Agrin Moeini, Roser Pinyol, Judit Peix, Laia Cabellos, Augusto Villanueva, Daniela Sia, Vincenzo Mazzaferro, Manel Esteller & Josep M. Llovet. (2019) Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. British Journal of Cancer 121:4, pages 340-343.
Crossref
Crossref
Patricia M. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe & Lisa H. Butterfield. (2019) Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells. Cancer Immunology Research 7:6, pages 1001-1012.
Crossref
Crossref
A. Rizzo, M. Galgano, M. Mutinati & R.L. Sciorsci. (2019) Alpha-fetoprotein in animal reproduction. Research in Veterinary Science 123, pages 281-285.
Crossref
Crossref
Wasila Mansouri, Samuel B. Fordyce, Matthew Wu, David Jones, Douglas Cohn, Qishan Lin, Paul Feustel, Tanuj Sharma, James A. Bennett & Thomas T. Andersen. (2018) Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties. Toxicology and Applied Pharmacology 345, pages 10-18.
Crossref
Crossref
Mehran Afshar, Peter Fletcher, Antonio D Bardoli, Yuk Ting Ma & Pankaj Punia. (2018) Non-secretion of AFP and neutrophil lymphocyte ratio as predictors for survival in hepatocellular carcinoma patients treated with sorafenib: a large UK cohort. Oncotarget 9:24, pages 16988-16995.
Crossref
Crossref
Murad Mollaev, Neonila Gorokhovets, Elena Nikolskaya, Maria Faustova, Arthur Zabolotsky, Maria Sokol, Oksana Tereshenko, Olga Zhunina, Vitaliy Shvets, Evgeniy Severin & Nikita Yabbarov. (2018) Recombinant alpha-fetoprotein receptor-binding domain co-expression with polyglutamate tags facilitates in vivo folding in E. coli. Protein Expression and Purification 143, pages 77-82.
Crossref
Crossref
Nikolai N. Belyaev, Nurshat Abdolla, Yuliya V. Perfilyeva, Yekaterina O. Ostapchuk, Vladimir K. Krasnoshtanov, Aikyn Kali & Raikhan Tleulieva. (2017) Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth. Cancer Immunology, Immunotherapy 67:1, pages 101-111.
Crossref
Crossref
Amr A. Fouad, Hatem O. Qutub, Abdullatif S. Al Rashed & Walid N. Al-Melhim. (2017) Therapeutic effect of carnosine in rat model of experimental liver carcinogenesis. Environmental Toxicology and Pharmacology 56, pages 10-14.
Crossref
Crossref
Bo Lin, Guoqing Peng, Haipeng Feng, Wei Li, Xu Dong, Yi Chen, Yan Lu, Qiaoyun Wang, Xieju Xie, Mingyue Zhu & Mengsen Li. (2017) Purification and characterization of a bioactive alpha-fetoprotein produced by HEK-293 cells. Protein Expression and Purification 136, pages 1-6.
Crossref
Crossref
Kiyoshi Ohkawa, Tadashi Asakura, Yutaka Tsukada & Tomokazu Matsuura. (2017) Antibody to human α-fetoprotein inhibits cell growth of human hepatocellular carcinoma cells by resuscitating the PTEN molecule: in vitro experiments. International Journal of Oncology 50:6, pages 2180-2190.
Crossref
Crossref
Raheleh Shakeri, Asma Kheirollahi & Jamshid Davoodi. (2017) Apaf-1: Regulation and function in cell death. Biochimie 135, pages 111-125.
Crossref
Crossref
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin & Vincenzo Canzonieri. (2016) Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 8:8, pages 14192-14220.
Crossref
Crossref
Stephen L. Chan, Anthony W. H. Chan & Simon C. H. Yu. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease
623
635
.
Chao Zhang, Hui Li, Wei Jiang, Xiaowei Zhang & Gang Li. (2016) Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation. Oncotarget 7:50, pages 83755-83766.
Crossref
Crossref
G. J. Mizejewski. (2016) The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins. Tumor Biology 37:9, pages 12697-12711.
Crossref
Crossref
Lisa H. Butterfield. (2016) Lessons learned from cancer vaccine trials and target antigen choice. Cancer Immunology, Immunotherapy 65:7, pages 805-812.
Crossref
Crossref
Huixiao Hong, Jie Shen, Hui Ng, Sugunadevi Sakkiah, Hao Ye, Weigong Ge, Ping Gong, Wenming Xiao & Weida Tong. (2016) A Rat α-Fetoprotein Binding Activity Prediction Model to Facilitate Assessment of the Endocrine Disruption Potential of Environmental Chemicals. International Journal of Environmental Research and Public Health 13:4, pages 372.
Crossref
Crossref
Stephen L. Chan, Anthony W. H. Chan & Simon C. H. Yu. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease
1
13
.
Angela D. Pardee, Hiroshi Yano, Aliyah M. Weinstein, Aaron A. K. Ponce, Alexander D. Ethridge, Daniel P. Normolle, Lazar Vujanovic, Gerald J. Mizejewski, Simon C. Watkins & Lisa H. Butterfield. (2015) Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Crossref
G. J. Mizejewski. (2015) Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary. Tumor Biology 36:12, pages 9857-9864.
Crossref
Crossref
Chao Zhang, Xiangmei Chen, Hui Liu, Hui Li, Wei Jiang, Wenting Hou, Michael A. McNutt, Fengmin Lu & Gang Li. (2015) Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm. International Journal of Cancer 137:8, pages 1818-1829.
Crossref
Crossref
Roula Tahtouh, Anne-Sophie Azzi, Nada Alaaeddine, Soulaima Chamat, Hasnaa Bouharoun-Tayoun, Layal Wardi, Issam Raad, Riad Sarkis, Najibe Abou Antoun & George Hilal. (2015) Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study. PLOS ONE 10:3, pages e0119512.
Crossref
Crossref
Mingyue Zhu, Junli Guo, Hua Xia, Wei Li, Yan Lu, Xu Dong, Yi Chen, Xieju Xie, Shigan Fu & Mengsen Li. (2015) Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells. Oncoscience 2:1, pages 59-70.
Crossref
Crossref
Angela D. Pardee, Jian Shi & Lisa H. Butterfield. (2014) Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells. The Journal of Immunology 193:11, pages 5723-5732.
Crossref
Crossref
Jun Zhang, Rui Wang, Min Cai, Shunji Yu, Yanyun Ma, Weihong Xu, Chunfang Gao, Jiucun Wang, Lifang Hou, Yi Liu & Jie Liu. (2014) Association of microRNA-3144 variant with the susceptibility to hepatocellular carcinoma. Genes & Genomics 36:6, pages 771-776.
Crossref
Crossref
Vladimir Pak. (2014) The use of α-fetoprotein for the delivery of cytotoxic payloads to cancer cells. Therapeutic Delivery 5:8, pages 885-892.
Crossref
Crossref
Lisa H Butterfield, James S Economou, T Gamblin & David A Geller. (2014) Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. Journal of Translational Medicine 12:1, pages 86.
Crossref
Crossref
Ekaterina Zubkova, Lidiya Semenkova, Elena Dudich, Igor Dudich, Yelena Parfyonova & Mikhail Menshikov. (2013) RETRACTED ARTICLE: Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways. Molecular and Cellular Biochemistry 379:1-2, pages 283-293.
Crossref
Crossref
Huixiao Hong, William S. Branham, Stacey L. Dial, Carrie L. Moland, Hong Fang, Jie Shen, Roger Perkins, Daniel Sheehan & Weida Tong. (2012) Rat α-Fetoprotein Binding Affinities of a Large Set of Structurally Diverse Chemicals Elucidated the Relationships between Structures and Binding Affinities. Chemical Research in Toxicology 25:11, pages 2553-2566.
Crossref
Crossref
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino & Giuseppe Stefano Calvagno. (2012) Hepatocellualar Carcinoma Serum Markers. Seminars in Oncology 39:4, pages 410-433.
Crossref
Crossref
Shanshan Wang, Wei Jiang, Xiangmei Chen, Chao Zhang, Hui Li, Wenting Hou, Zhongmin Liu, Michael A. McNutt, Fengmin Lu & Gang Li. (2012) Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma. Journal of Hepatology 57:2, pages 322-329.
Crossref
Crossref
Goshi Shiota & Norimasa Miura. (2012) Biomarkers for hepatocellular carcinoma. Clinical Journal of Gastroenterology 5:3, pages 177-182.
Crossref
Crossref
A. V. Morozov, V. A. Morozov, T. M. Astakhova, A. V. Timofeev & V. L. Karpov. (2012) DNA vaccine encoding α-fetoprotein fused with the ornithine decarboxylase degradation signal significantly suppresses the hepatocellular carcinoma growth in mice. Molecular Biology 46:3, pages 391-406.
Crossref
Crossref
ALEXANDER A. TERENTIEV, NURBUBU T. MOLDOGAZIEVA, OLGA V. LEVTSOVA, DMITRY M. MAXIMENKO, DENIS A. BOROZDENKO & KONSTANTIN V. SHAITAN. (2012) MODELING OF THREE DIMENSIONAL STRUCTURE OF HUMAN ALPHA-FETOPROTEIN COMPLEXED WITH DIETHYLSTILBESTROL: DOCKING AND MOLECULAR DYNAMICS SIMULATION STUDY. Journal of Bioinformatics and Computational Biology 10:02, pages 1241012.
Crossref
Crossref
Chaoying Li, Shanshan Wang, Wei Jiang, Hui Li, Zhongmin Liu, Chao Zhang, Michael A. McNutt & Gang Li. (2011) Impact of intracellular alpha fetoprotein on retinoic acid receptors‐mediated expression of GADD153 in human hepatoma cell lines. International Journal of Cancer 130:4, pages 754-764.
Crossref
Crossref
Gerald Mizejewski. (2011) Mechanism of Cancer Growth Suppression of Alpha-Fetoprotein Derived Growth Inhibitory Peptides (GIP): Comparison of GIP-34 versus GIP-8 (AFPep). Updates and Prospects. Cancers 3:2, pages 2709-2733.
Crossref
Crossref
Gerald J. Mizejewski. (2010) Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family. Tumor Biology 32:2, pages 241-258.
Crossref
Crossref
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Massimiliano Berretta, Alessandro Cappellani & Mariano Malaguarnera. (2010) Serum Markers of Hepatocellular Carcinoma. Digestive Diseases and Sciences 55:10, pages 2744-2755.
Crossref
Crossref
Penelope Brock, Derek J. Roebuck & Jack Plaschkes. 2010. Pediatric Hematology and Oncology. Pediatric Hematology and Oncology
258
274
.
Herbert I. Jacobson, Nicole Lemanski, Anu Agarwal, Amithi Narendran, Kelvin E. TurnerIIII, James A. Bennett & Thomas T. Andersen. (2010) A Proposed Unified Mechanism for the Reduction of Human Breast Cancer Risk by the Hormones of Pregnancy. Cancer Prevention Research 3:2, pages 212-220.
Crossref
Crossref
Xavier Rogiers & Ruth De Bruyne. 2010. Malignant Liver Tumors. Malignant Liver Tumors
475
486
.
AI Potapovich, S Pastore, VA Kostyuk, D Lulli, V Mariani, C De Luca, EI Dudich & LG Korkina. (2009) α‐Fetoprotein as a modulator of the pro‐inflammatory response of human keratinocytes. British Journal of Pharmacology 158:5, pages 1236-1247.
Crossref
Crossref
Mengsen Li, Hui Li, Chaoying Li, Liyuan Guo, Han Liu, Sheng Zhou, Xinhua Liu, Zhuo Chen, Shuanglin Shi, Jiang Wei, Michael A. McNutt & Gang Li. (2009) Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells. Cancer Letters 285:2, pages 190-199.
Crossref
Crossref
Stephen L Chan, Anthony TC Chan & Winnie Yeo. (2009) Role of α-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?. Future Oncology 5:6, pages 889-899.
Crossref
Crossref
Gerald J. Mizejewski. (2008) Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunology, Immunotherapy 58:2, pages 159-170.
Crossref
Crossref
Rajasree Menon, Qing Zhang, Yan Zhang, Damian Fermin, Nabeel Bardeesy, Ronald A. DePinho, Chunxia Lu, Samir M. Hanash, Gilbert S. Omenn & David J. States. (2009) Identification of Novel Alternative Splice Isoforms of Circulating Proteins in a Mouse Model of Human Pancreatic Cancer. Cancer Research 69:1, pages 300-309.
Crossref
Crossref
Jung Rok Lee, Juhee Lee, Sang Kyung Kim, Kwang Pyo Kim, Hyung Soon Park & Woon-Seok Yeo. (2008) Mass Spectrometry Signal Amplification Method for Attomolar Detection of Antigens Using Small-Molecule-Tagged Gold Microparticles. Angewandte Chemie International Edition 47:49, pages 9518-9521.
Crossref
Crossref
Jung Rok Lee, Juhee Lee, Sang Kyung Kim, Kwang Pyo Kim, Hyung Soon Park & Woon-Seok Yeo. (2008) Mass Spectrometry Signal Amplification Method for Attomolar Detection of Antigens Using Small-Molecule-Tagged Gold Microparticles. Angewandte Chemie 120:49, pages 9660-9663.
Crossref
Crossref
Xiaojun Yang, Youcheng Zhang, Lingyi Zhang, Lin Zhang & Jie Mao. (2008) Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Letters 271:2, pages 281-293.
Crossref
Crossref
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura & Masaru Miyazaki. (2008) Clinical significance of -fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 23:7pt2, pages e189-e197.
Crossref
Crossref
Gerald J. Mizejewski. (2016) Physiology of Alpha-Fetoprotein as a Biomarker for Perinatal Distress: Relevance to Adverse Pregnancy Outcome. Experimental Biology and Medicine 232:8, pages 993-1004.
Crossref
Crossref
Dolores López-Terrada & Milton J. Finegold. 2009. Liver Disease in Children. Liver Disease in Children
943
974
.
Gerald J. Mizejewski. (2007) The Alpha-Fetoprotein–Derived Growth Inhibitory Peptide 8-Mer Fragment: Review of a Novel Anticancer Agent. Cancer Biotherapy and Radiopharmaceuticals 22:1, pages 73-98.
Crossref
Crossref
A. A. Terentiev & N. T. Moldogazieva. (2006) Structural and functional mapping of α-fetoprotein. Biochemistry (Moscow) 71:2, pages 120-132.
Crossref
Crossref
Jiong Zhou, Takashi Suzuki, Agnes Kovacic, Ryoko Saito, Yasuhiro Miki, Takanori Ishida, Takuya Moriya, Evan R. Simpson, Hironobu Sasano & Colin D. Clyne. (2005) Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer. Cancer Research 65:2, pages 657-663.
Crossref
Crossref
O. N. Ilinskaya & A. A. Makarov. (2005) Why ribonucleases induce tumor cell death. Molecular Biology 39:1, pages 1-10.
Crossref
Crossref
Shian‐Yang Peng, Wei J. Chen, Po‐Lin Lai, Yun‐Ming Jeng, Jin‐Chuan Sheu & Hey‐Chi Hsu. (2004) High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutations. International Journal of Cancer 112:1, pages 44-50.
Crossref
Crossref
Lakita G. Cavin, Manickam Venkatraman, Valentina M. Factor, Swayamjot Kaur, Insa Schroeder, Frank Mercurio, Amer A. Beg, Snorri S. Thorgeirsson & Marcello Arsura. (2004) Regulation of α-Fetoprotein by Nuclear Factor-κB Protects Hepatocytes from Tumor Necrosis Factor-α Cytotoxicity during Fetal Liver Development and Hepatic Oncogenesis. Cancer Research 64:19, pages 7030-7038.
Crossref
Crossref
Gerald J. Mizejewski. (2016) Biological Roles of Alpha-Fetoprotein During Pregnancy and Perinatal Development. Experimental Biology and Medicine 229:6, pages 439-463.
Crossref
Crossref